CHARLES RIVER LABORATORIES conducted an 8-month Return on Investment (ROI) pilot study on the use of Augmentiqs for real-time telepathology. The study looked at savings in pathologist work hours, cycle time and logistic expenses.
Over the course of the study period, Augmentiqs was utilized by the remote CRL pathologists for numerous reasons including i) internal CRL telepathology consultation between the remote and on-site pathologists, ii) external client telepathology consultation, iii) online peer-review with external clients, and iv) capturing publication-grade images.